» Articles » PMID: 25060907

Taurine Prevents High Glucose-induced Angiopoietin-2/tie-2 System Alterations and Apoptosis in Retinal Microvascular Pericytes

Overview
Publisher Springer
Specialty Biochemistry
Date 2014 Jul 26
PMID 25060907
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Previously, we confirmed that taurine prevented diabetes-induced apoptosis in retinal glial cells via its anti-oxidation and anti-glutamate excitotoxicity mechanisms. The aim of this study is to investigate the effects of taurine on angiopoietin-2 (Ang-2)/Tie-2 system expressions and apoptosis in high glucose-treated retinal microvascular pericytes (RMPs). Also, the possible mechanism involved in the inhibition of taurine on RMPs apoptosis is investigated. The expressions of Ang-2, Tie-2 were detected by qRT-PCR and ELISA. The level of phosphorylated Tie-2 (P-Tie-2) was examined by ELISA. Hoechst 33342 and Annexin V/PI staining were used to detect RMPs apoptosis. The activity of caspase-3 was detected by assay kit. In 25 mM high glucose group, the expression of Ang-2 was increased significantly, taurine down-regulated Ang-2 in a dose (0.1, 1, and 10 mM)-dependent manner (P < 0.05). The Tie-2 expression and P-Tie-2 level were decreased in high glucose group (P < 0.05). Interestingly, taurine at 1 and 10 mM showed significant increase in Tie-2 expression and P-Tie-2 level (P < 0.05). The number of apoptotic RMPs and the activity of caspase-3 increased in the presence of high glucose (P < 0.05). Treatment with taurine at 1 mM decreased the number of apoptotic RMPs and the activity of caspase-3 (P < 0.05). Blocking antibody and small interfering RNA (siRNA) treatment showed that taurine required Tie-2 to perform its anti-apoptotic effect. Taken together, our data suggest that high glucose-induced Ang-2/Tie-2 system expressions alteration can be reversed by taurine, and that taurine can inhibit high glucose-induced RMPs apoptosis via Tie-2.

Citing Articles

Arterial Hypertension and the Hidden Disease of the Eye: Diagnostic Tools and Therapeutic Strategies.

Del Pinto R, Mule G, Vadala M, Carollo C, Cottone S, Agabiti Rosei C Nutrients. 2022; 14(11).

PMID: 35683999 PMC: 9182467. DOI: 10.3390/nu14112200.


The Relationship between Plasma Taurine Levels and Diabetic Complications in Patients with Type 2 Diabetes Mellitus.

Sak D, Erdenen F, Muderrisoglu C, Altunoglu E, Sozer V, Gungel H Biomolecules. 2019; 9(3).

PMID: 30862074 PMC: 6468751. DOI: 10.3390/biom9030096.


A review of therapies for diabetic macular oedema and rationale for combination therapy.

Amoaku W, Saker S, Stewart E Eye (Lond). 2015; 29(9):1115-30.

PMID: 26113500 PMC: 4565941. DOI: 10.1038/eye.2015.110.

References
1.
Jones N, Master Z, Jones J, Bouchard D, Gunji Y, Sasaki H . Identification of Tek/Tie2 binding partners. Binding to a multifunctional docking site mediates cell survival and migration. J Biol Chem. 1999; 274(43):30896-905. DOI: 10.1074/jbc.274.43.30896. View

2.
Rangasamy S, Srinivasan R, Maestas J, McGuire P, Das A . A potential role for angiopoietin 2 in the regulation of the blood-retinal barrier in diabetic retinopathy. Invest Ophthalmol Vis Sci. 2011; 52(6):3784-91. PMC: 3109054. DOI: 10.1167/iovs.10-6386. View

3.
Pfister F, Feng Y, Vom Hagen F, Hoffmann S, Molema G, Hillebrands J . Pericyte migration: a novel mechanism of pericyte loss in experimental diabetic retinopathy. Diabetes. 2008; 57(9):2495-502. PMC: 2518502. DOI: 10.2337/db08-0325. View

4.
Hansen S . The role of taurine in diabetes and the development of diabetic complications. Diabetes Metab Res Rev. 2001; 17(5):330-46. DOI: 10.1002/dmrr.229. View

5.
Zeng K, Xu H, Mi M, Zhang Q, Zhang Y, Chen K . Dietary taurine supplementation prevents glial alterations in retina of diabetic rats. Neurochem Res. 2008; 34(2):244-54. DOI: 10.1007/s11064-008-9763-0. View